|
KDM2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.80026999999638E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.605300E-04 |
| Normal-vs-Stage2 |
4.991100E-04 |
| Normal-vs-Stage3 |
1.109550E-02 |
| Normal-vs-Stage4 |
4.854400E-01 |
| Stage1-vs-Stage2 |
1.563950E-01 |
| Stage1-vs-Stage3 |
9.199800E-01 |
| Stage1-vs-Stage4 |
3.859600E-01 |
| Stage2-vs-Stage3 |
1.891030E-01 |
| Stage2-vs-Stage4 |
1.368190E-01 |
| Stage3-vs-Stage4 |
4.526000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.603650E-04 |
| Normal-vs-AfricanAmerican |
1.85993999999301E-05 |
| Normal-vs-Asian |
3.212800E-01 |
| Caucasian-vs-AfricanAmerican |
5.840000E-02 |
| Caucasian-vs-Asian |
9.386000E-02 |
| AfricanAmerican-vs-Asian |
6.221300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.51830000000897E-05 |
| Normal-vs-Female |
1.53224999999146E-05 |
| Male-vs-Female |
1.605400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.049870E-02 |
| Normal-vs-Extreme_Weight |
3.217000E-03 |
| Normal-vs-Obese |
2.580000E-04 |
| Normal-vs-Extreme_Obese |
1.191760E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.471800E-01 |
| Normal_Weight-vs-Obese |
4.214600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.200000E-01 |
| Extreme_Weight-vs-Obese |
2.459000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.926600E-01 |
| Obese-vs-Extreme_Obese |
4.163000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.968050E-04 |
| Normal-vs-Age(41-60Yrs) |
5.8294999999986E-05 |
| Normal-vs-Age(61-80Yrs) |
4.645600E-04 |
| Normal-vs-Age(81-100Yrs) |
4.141200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.645000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.331410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.752000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.369580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.566100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.289800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.47580000001246E-06 |
| Normal-VS-Type2 PRCC |
4.797200E-01 |
| Normal-VS-KIRP CIMP |
3.180400E-02 |
| Normal-VS-Unclassified PRCC |
1.165320E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.13260000045301E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.513000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.029800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.431610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.841200E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.126360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.583900E-02 |
| Normal-vs-N1 |
2.597500E-03 |
| Normal-vs-N2 |
7.572600E-01 |
| N0-vs-N1 |
1.330430E-01 |
| N0-vs-N2 |
1.411180E-01 |
| N1-vs-N2 |
1.602150E-02 |
|
|
